Entyvio Injection, Powder, Lyophilized, For Solution
Product Images NDC 64764-300

33 FDA label images from Takeda Pharmaceuticals America, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 33 technical images submitted to the FDA as part of the official labeling for Entyvio (NDC 64764-300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Entyvio 01)

Image (Entyvio 01)
Label for ENTYVIO Pen injection, containing vedolizumab at 300 mg per vial strength. It is a single-dose vial for intravenous use only, requiring reconstitution and dilution before administration. The label includes dosage information, storage instructions, lot number, and expiration date fields. The labeler is Takeda Pharmaceuticals America, Inc.*
FDA Label Image

Figure A (Entyvio 02)

Figure A (Entyvio 02)
Packaging label for Entyvio vedolizumab injection 300 mg per vial by Takeda Pharmaceuticals America, Inc. The label specifies the product is for intravenous use only, requires reconstitution and dilution prior to use, and is a single-dose vial. It includes storage instructions and a statement about receiving the enclosed medication guide.*
FDA Label Image

Figure B (Entyvio 03)

Figure B (Entyvio 03)
An instructional illustration for the ENTYVIO Pen subcutaneous injection showing a clock indicating to wait 30 minutes next to a box, likely representing the medication packaging.*
FDA Label Image

Figure C (Entyvio 04)

Figure C (Entyvio 04)
An instructional illustration depicting a red sharps container with a gray lid alongside various medical waste items, including round tablets and single-use packaging materials, indicating safe disposal of medication-related waste.*
FDA Label Image

Figure D (Entyvio 05)

Figure D (Entyvio 05)
An illustration showing hands being washed under running water from a faucet, demonstrating proper handwashing technique with water flowing over both hands and soap lathered on the skin.*
FDA Label Image

Figure E (Entyvio 06)

Figure E (Entyvio 06)
An instructional illustration showing a hand peeling back the protective cover of a medical device or packaging tray by lifting a flap upwards, indicated by two gray arrows pointing away from the base.*
FDA Label Image

Figure F (Entyvio 07)

Figure F (Entyvio 07)
Illustration of the ENTYVIO Pen injection device showing where to check the expiration date and the medicine inside the pen. Labels point to the expiration date window and the medicine chamber, emphasizing verification steps before use.*
FDA Label Image

Figure G (Entyvio 08)

Figure G (Entyvio 08)
An instructional anatomical diagram showing recommended injection sites for ENTYVIO Pen injection solution. For self-administration, the front illustration highlights the stomach area and thigh as injection sites. The back illustration shows the back of the arms as an injection site labeled for caregiver use only.*
FDA Label Image

Figure H (Entyvio 09)

Figure H (Entyvio 09)
An instructional illustration showing a hand wiping an area of skin with a cloth or swab, likely depicting skin preparation before an injection. The image relates to the subcutaneous injection process for the ENTYVIO Pen (vedolizumab).*
FDA Label Image

Figure I (Entyvio 10)

Figure I (Entyvio 10)
An instructional illustration showing hands removing a purple cap from an ENTYVIO Pen injection device. The pen is held near a sharps disposal container, indicating proper disposal of the cap after removal.*
FDA Label Image

Figure J (Entyvio 11)

Figure J (Entyvio 11)
An instructional illustration showing a hand holding an ENTYVIO Pen injection device vertically at a 90-degree angle to a flat surface, demonstrating proper injection positioning for subcutaneous administration.*
FDA Label Image

Figure K And Figure L (Entyvio 12)

Figure K And Figure L (Entyvio 12)
An instructional diagram showing the use of the ENTYVIO Pen injection device. It illustrates three steps: pushing and holding to start the injection with a click sound, continuing to hold during the ongoing injection with a second click, and checking the window to confirm the injection is complete with a visual indicator.*
FDA Label Image

Figure M (Entyvio 13)

Figure M (Entyvio 13)
An instructional illustration showing a hand gripping an ENTYVIO Pen injection device vertically, with an upward-pointing arrow indicating the direction to pull or lift the pen from a surface. The pen features a visible window with a purple indicator and a yellow cap at the bottom.*
FDA Label Image

Figure N (Entyvio 14)

Figure N (Entyvio 14)
An instructional illustration depicting a hand disposing of a used medical syringe or autoinjector into a red sharps disposal container. The image emphasizes safe disposal practices for injection devices, relevant to products like ENTYVIO Pen (vedolizumab) subcutaneous injection.*
FDA Label Image

Image (Entyvio 15)

Image (Entyvio 15)
Illustration showing the components and mechanism of an ENTYVIO Pen injection device before and after use. Key parts labeled include the purple plunger, finger grip, expiration date, medicine, needle, needle cap, needle guard, and spring. After use, the needle is covered by the needle guard for safety.*
FDA Label Image

Figure A (Entyvio 16)

Figure A (Entyvio 16)
Illustration showing a hand removing or placing a pharmaceutical carton from or onto a shelf, indicating medication storage or retrieval.*
FDA Label Image

Figure B (Entyvio 17)

Figure B (Entyvio 17)
An instructional illustration showing a clock with a 30-minute mark and the text 'Wait 30 Minutes' next to a rectangular box with a partially purple top. This image likely indicates a waiting period after handling the box or its contents.*
FDA Label Image

Figure C (Entyvio 18)

Figure C (Entyvio 18)
An illustration depicting a red biohazard sharps container alongside medical waste items including a used syringe, cotton balls, and alcohol prep pads, indicating proper disposal of injection materials.*
FDA Label Image

Figure D (Entyvio 19)

Figure D (Entyvio 19)
An instructional illustration showing hands being washed under a running faucet with water flowing, emphasizing thorough hand cleaning with soap to produce lather before injection preparation.*
FDA Label Image

Figure E (Entyvio 20)

Figure E (Entyvio 20)
An instructional illustration showing a hand holding an ENTYVIO Pen, a prefilled subcutaneous injection device containing vedolizumab. The image depicts the use of the autoinjector within its packaging tray, highlighting the grip and injection mechanism.*
FDA Label Image

Figure F (Entyvio 21)

Figure F (Entyvio 21)
An instructional illustration showing a prefilled pen syringe with an emphasis on visually checking the expiration date and the medicine inside. The image includes a large eye symbol and dotted lines pointing towards the label on the syringe, indicating the user should verify these details before use.*
FDA Label Image

Figure G (Entyvio 22)

Figure G (Entyvio 22)
An instructional medical illustration showing recommended subcutaneous injection sites for ENTYVIO Pen. Injection areas on the front include the stomach and thigh, and on the back, injection sites on the back of the arms are indicated for use by a caregiver only.*
FDA Label Image

Figure H (Entyvio 23)

Figure H (Entyvio 23)
An illustration showing a hand holding a cotton ball or gauze pad and pressing it onto a skin surface, depicting a step likely related to preparing or caring for an injection site.*
FDA Label Image

Figure I (Entyvio 24)

Figure I (Entyvio 24)
An instructional illustration showing two hands: one holding the cap of an injection pen being removed, and the other holding the pen with needle exposed, positioned above a sharps disposal container, indicating safe disposal of the pen's needle or cap.*
FDA Label Image

Figure J (Entyvio 25)

Figure J (Entyvio 25)
An instructional illustration showing a hand pinching the skin on the forearm, demonstrating a subcutaneous injection technique.*
FDA Label Image

Figure K (Entyvio 26)

Figure K (Entyvio 26)
An instructional illustration showing how to hold and angle the ENTYVIO Pen subcutaneous injection at approximately a 45-degree angle to the skin prior to injection. The image depicts a hand administering the injection into the forearm or lower arm area.*
FDA Label Image

Figure L (Entyvio 27)

Figure L (Entyvio 27)
An instructional illustration showing a hand holding a prefilled injection pen administering a subcutaneous injection into the skin of the opposite forearm or hand. The pen is shown being pressed against the skin to deliver the dose.*
FDA Label Image

Figure M (Entyvio 28)

Figure M (Entyvio 28)
An instructional illustration showing a hand holding an ENTYVIO Pen subcutaneous injection device. The image depicts the user pulling the cap off the pen, indicated by an upward arrow above the device, demonstrating the first step in preparing the injection.*
FDA Label Image

Figure N (Entyvio 29)

Figure N (Entyvio 29)
An instructional illustration showing a hand pressing down the plunger of a syringe into a red sharps disposal container to safely discard the needle and syringe, associated with ENTYVIO Pen subcutaneous injection use.*
FDA Label Image

Principal Display Panel (300 mg Vial Label)

Principal Display Panel (300 mg Vial Label)
Label for ENTYVIO (vedolizumab) injection, 300 mg per vial. This single-dose vial is for intravenous use only and must be reconstituted and diluted prior to use. Manufactured by Takeda Pharmaceuticals America, Inc., the label includes dosage and storage information, barcode, lot number, and expiration date sections.*
FDA Label Image

Principal Display Panel (300 mg Vial Carton)

Principal Display Panel (300 mg Vial Carton)
Carton packaging label for Entyvio (vedolizumab) injection, 300 mg per vial. The label includes dosing and storage instructions, manufacturer Takeda Pharmaceuticals U.S.A., Inc., and specifies that it is for intravenous use only. The label also highlights the need to reconstitute and dilute the single-dose vial prior to use and discard any unused portion.*
FDA Label Image

Principal Display Panel (108 mg/0.68 mL Pen Tray Carton)

Principal Display Panel (108 mg/0.68 mL Pen Tray Carton)
Packaging label for ENTYVIO Pen 108 mg/0.68 mL injection, a subcutaneous solution of vedolizumab. The label shows a single-dose prefilled pen with purple and yellow accents. It includes the proprietary name, generic name, strength, dosage form, route of administration, and instructions to pharmacists to provide the Medication Guide. Labeler is Takeda Pharmaceuticals America, Inc.*
FDA Label Image

Principal Display Panel (108 mg/0.68 mL Syringe Tray Carton)

Principal Display Panel (108 mg/0.68 mL Syringe Tray Carton)
Packaging label for ENTYVIO Pen (vedolizumab) injection, 108 mg/0.68 mL strength. The label indicates the product is for subcutaneous use only and comes as a single-dose prefilled syringe. The labeler is Takeda Pharmaceuticals America, Inc. The packaging includes instructions for pharmacists and a visual of a syringe.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.